{"id":"https://openalex.org/W2979816083","doi":"https://doi.org/10.1182/blood.v116.21.1924.1924","title":"Elevated Homologous Recombination Induces Karyotypic Changes and Predicts Poor Clinical Outcome In Multiple Myeloma","display_name":"Elevated Homologous Recombination Induces Karyotypic Changes and Predicts Poor Clinical Outcome In Multiple Myeloma","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2979816083","doi":"https://doi.org/10.1182/blood.v116.21.1924.1924","mag":"2979816083"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.1924.1924","doi":"https://doi.org/10.1182/blood.v116.21.1924.1924","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.1924.1924","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040654673","display_name":"Jagannath Pal","orcid":"https://orcid.org/0000-0002-7110-4048","observed_orcids":["https://orcid.org/0000-0002-7110-4048"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jagannath Pal","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073180479","display_name":"Jeffrey R. Sawyer","orcid":"https://orcid.org/0000-0001-8461-8614","observed_orcids":["https://orcid.org/0000-0001-8461-8614"]},"institutions":[{"id":"https://openalex.org/I1301864278","display_name":"Arkansas Children's Hospital","ror":"https://ror.org/01t33qq42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301864278"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey Sawyer","raw_affiliation_strings":["Arkansas Children's Hospital,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arkansas Children's Hospital,","institution_ids":["https://openalex.org/I1301864278"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057939952","display_name":"Samirkumar B. Amin","orcid":"https://orcid.org/0000-0002-3207-9505","observed_orcids":["https://orcid.org/0000-0002-3207-9505"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samir B. Amin","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100354234","display_name":"Cheng Li","orcid":"https://orcid.org/0000-0002-0449-3709","observed_orcids":["https://orcid.org/0000-0002-0449-3709"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cheng Li","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017577287","display_name":"Puru Nanjappa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Puru Nanjappa","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071970744","display_name":"Saem Lee","orcid":"https://orcid.org/0000-0002-5903-2299","observed_orcids":["https://orcid.org/0000-0002-5903-2299"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Saem Lee","raw_affiliation_strings":["VA Boston Healthcare System, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073612758","display_name":"St\u00e9phane Minvielle","orcid":"https://orcid.org/0000-0003-1389-312X","observed_orcids":["https://orcid.org/0000-0003-1389-312X"]},"institutions":[{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Stephane Minvielle","raw_affiliation_strings":["U, Nantes, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U, Nantes, France,","institution_ids":["https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve\u0301 Avet-Loiseau","raw_affiliation_strings":["Hematology, CHU, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, CHU, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Masood Shammas","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5017577287","https://openalex.org/A5040654673","https://openalex.org/A5063099799","https://openalex.org/A5071970744","https://openalex.org/A5073180479","https://openalex.org/A5073612758","https://openalex.org/A5100354234"],"corresponding_institution_ids":["https://openalex.org/I1301864278","https://openalex.org/I2801671727","https://openalex.org/I4210117453","https://openalex.org/I97188460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42670804,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"21","first_page":"1924","last_page":"1924"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.972000002861023},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.9150000214576721},{"id":"https://openalex.org/keywords/karyotypic-instability","display_name":"karyotypic instability","score":0.9440000057220459},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.847000002861023},{"id":"https://openalex.org/keywords/chromosome-7","display_name":"chromosome 7","score":0.3619999885559082},{"id":"https://openalex.org/keywords/chromosome-14","display_name":"chromosome 14","score":0.9769999980926514},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.5139999985694885},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6399999856948853},{"id":"https://openalex.org/keywords/clinical-outcome-prediction","display_name":"clinical outcome prediction","score":0.6629999876022339},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5460000038146973},{"id":"https://openalex.org/keywords/loss-of-heterozygosity","display_name":"loss of heterozygosity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/spectral-karyotyping","display_name":"spectral karyotyping","score":0.699999988079071},{"id":"https://openalex.org/keywords/snp-array","display_name":"SNP array","score":0.671999990940094},{"id":"https://openalex.org/keywords/shrna","display_name":"shRNA","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6933492422103882},{"id":"https://openalex.org/C140752955","wikidata":"https://www.wikidata.org/wiki/Q1087752","display_name":"Chromosome instability","level":4,"score":0.6487472057342529},{"id":"https://openalex.org/C53226629","wikidata":"https://www.wikidata.org/wiki/Q189967","display_name":"Karyotype","level":4,"score":0.6049091219902039},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5828328728675842},{"id":"https://openalex.org/C143589142","wikidata":"https://www.wikidata.org/wiki/Q2617554","display_name":"Loss of heterozygosity","level":4,"score":0.5714424848556519},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.5622828006744385},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5159945487976074},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.47629013657569885},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.4679493010044098},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4568856358528137},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44872161746025085},{"id":"https://openalex.org/C64894306","wikidata":"https://www.wikidata.org/wiki/Q849622","display_name":"Homologous chromosome","level":3,"score":0.4324692189693451},{"id":"https://openalex.org/C2778964538","wikidata":"https://www.wikidata.org/wiki/Q2090167","display_name":"Plasmacytoma","level":3,"score":0.412134051322937},{"id":"https://openalex.org/C177336024","wikidata":"https://www.wikidata.org/wiki/Q14872779","display_name":"Telomere","level":3,"score":0.41149190068244934},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.37112662196159363},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21911028027534485},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20596936345100403},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1774570345878601},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.14952918887138367},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.11162462830543518}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.1924.1924","doi":"https://doi.org/10.1182/blood.v116.21.1924.1924","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.1924.1924","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586049507","https://openalex.org/W2594634994","https://openalex.org/W2048888997","https://openalex.org/W2525392096","https://openalex.org/W2563288783","https://openalex.org/W3176076427","https://openalex.org/W2591224296","https://openalex.org/W2607199726","https://openalex.org/W2987391075","https://openalex.org/W2581763939"],"abstract_inverted_index":{"Abstract":[0,1],"1924":[2],"Homologous":[3],"recombination":[4,49],"(HR),":[5],"by":[6,296],"inducing":[7],"DNA":[8],"rearrangements,":[9],"plays":[10],"an":[11,430,442,453,464],"important":[12,338],"role":[13],"in":[14,55,82,95,100,115,179,207,247,314,351,395,404],"cancer":[15],"cell":[16],"proliferation":[17],"and":[18,47,64,72,77,103,122,130,158,170,210,346,406,419],"progression":[19,420],"via":[20],"induction":[21],"of":[22,30,67,79,143,149,155,161,175,201,236,254,262,282,310,330,411,421,433,445,456,467],"oncogene":[23],"activation,":[24],"and/or":[25],"anti-oncogene":[26],"inactivation":[27],"(or":[28],"loss":[29,253],"heterozygosity":[31],"at":[32],"tumor":[33],"suppressor":[34],"loci),":[35],"as":[36,38,59,61,139,194,275,293,295,399,401],"well":[37,60,294,400],"telomere-expansion.":[39],"We":[40,84,172,285,334],"have":[41,85,286,317],"observed":[42,173,335],"that":[43,336,390,408],"recombinase":[44,68,342],"(RAD51)":[45],"expression":[46,320,328,375],"homologous":[48],"(HR)":[50],"activity":[51],"are":[52,348],"constitutively":[53],"elevated":[54,93,391],"multiple":[56],"myeloma":[57,96],"(MM)":[58],"other":[62,229],"cancers,":[63],"the":[65,180,190,213,222,228,237,248,252,255,259,263,266,271,276,308,364,397],"suppression":[66],"(hsRAD51)":[69],"reduces":[70],"HR":[71,94,106,311,360,372,392,412],"significantly":[73,349,377],"inhibits":[74],"genomic":[75,417],"instability":[76,102,418],"development":[78],"drug":[80],"resistance":[81],"MM.":[83,116],"further":[86,306],"extended":[87],"these":[88,359],"observations":[89],"to":[90,111,382],"investigate":[91],"whether":[92],"is":[97,393],"also":[98],"implicated":[99,394],"karyotypic":[101,133,177,402],"if":[104],"prominent":[105],"genes":[107,340,362],"can":[108],"be":[109],"used":[110],"predict":[112],"clinical":[113],"outcome":[114,313],"Myeloma":[117],"cells,":[118,279],"transduced":[119,183,268],"with":[120,165,204,290,370,384],"control":[121,145,181],"RAD51":[123],"shRNAs,":[124],"were":[125],"cultured":[126],"for":[127,132],"30":[128,186],"days":[129],"evaluated":[131],"changes":[134,403],"using":[135,301,327,358],"\u201cday":[136],"0\u201d":[137],"cells":[138,146,184,269],"reference.":[140],"G-band":[141],"karyotype":[142,193],"baseline":[144,277],"showed":[147,197,218,233,270],"number":[148,299],"chromosomal":[150],"abnormalities":[151],"including":[152,341],"three":[153,159],"copies":[154,160],"chromosome":[156,162,216,231],"7;":[157],"14":[163,250],"each":[164],"different":[166],"aberrations:":[167],"add(14)(q32),":[168],"add(14)(q24.3),":[169],"der(14)t(3;14)(p13;p11.2)add(14)(q24.3).":[171],"acquisition":[174,281],"new":[176,283],"change":[178,244,300],"shRNA":[182],"after":[185],"days.":[187],"Besides":[188],"retaining":[189],"same":[191,272],"stemline":[192,273],"baseline,":[195],"it":[196],"a":[198,234,242],"sideline":[199],"(3":[200],"20":[202],"cells)":[203],"additional":[205,219],"aberrations":[206,274],"chromosomes":[208,249],"7":[209,217,232],"14.":[211],"In":[212],"sideline,":[214],"one":[215],"material":[220,257],"on":[221,312,429,441,452,463],"distal":[223],"short":[224,238,260],"arm,":[225,239],"add(7)(p22),":[226],"while":[227],"abnormal":[230],"deletion":[235],"del(7)(p12).":[240],"Only":[241],"single":[243],"was":[245],"identified":[246],"involving":[251],"3p":[256],"from":[258,322],"arm":[261],"der(14)t(3;14).":[264],"Interestingly,":[265],"recombinase-shRNA":[267],"reference":[278],"without":[280],"change.":[284],"confirmed":[287],"similar":[288],"results":[289],"spectral":[291],"karyotyping":[292],"analyzing":[297],"copy":[298],"high-density":[302],"SNP":[303],"array.":[304],"To":[305],"analyze":[307],"impact":[309],"MM,":[315,405],"we":[316],"analyzed,":[318],"gene":[319,374],"data":[321,388],"170":[323],"uniformly":[324],"treated":[325],"patients":[326,353,365,369],"levels":[329],"155":[331],"HR-related":[332,339],"genes.":[333],"several":[337],"(HsRAD51),":[343],"XRCC2,":[344],"ERCC1,":[345],"endonucleases":[347],"upregulated":[350],"MM":[352],"(P<0.05).":[354],"Unsupervised":[355],"hierarchical":[356],"clustering":[357],"related":[361,373],"divided":[363],"into":[366],"two":[367],"groups;":[368],"higher":[371],"had":[376],"poor":[378],"overall":[379],"survival":[380],"compared":[381],"those":[383],"lower":[385],"expression.":[386],"These":[387],"confirm":[389],"both":[396],"mutational":[398],"suggest":[407],"suitable":[409],"inhibitors":[410],"may":[413],"reduce":[414],"or":[415,435,447,458,469],"prevent":[416],"disease.":[422],"Disclosures:":[423],"Munshi:":[424],"Millennium":[425],"Pharmaceuticals:":[426],"Honoraria,":[427],"Membership":[428,440,451,462],"entity's":[431,443,454,465],"Board":[432,444,455,466],"Directors":[434,446,457,468],"advisory":[436,448,459,470],"committees;":[437,449,460],"Celgene:":[438],"Consultancy,":[439],"Novartis:":[450],"Onyx:":[461],"committees.":[471]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-10-18T00:00:00"}